R&D Can genetic data be a magic bullet for drug R&D? Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.